A Santa Fe, New Mexico startup is heading to Washington, D.C., next month to put its bacterial lung infection breath testing capabilities up against other small tech firms.
Avisa Pharma Inc., is one of 35 businesses nationwide to earn a spot at the National Council of Entrepreneurial Tech Transfer’s Demo Day at the U.S. Capitol on Sept. 20. Participating startups each get six minutes to present their product to potential investors and representatives from Fortune 500 and Global 1000 companies.
The company relies on technology originally developed by two University of New Mexico professors and licenses it from the institution. The product quickly measures the bacteria level in the lungs to determine whether a patient has tuberculosis, bacterial pneumonia or another bacteria-borne disease.
From the Albuquerque Journal:
A second round of 17 startups will be announced next week, and five more UNM startups are on the short list of 80 companies still in the running to win a spot at Demo Day. That’s more than any other university nationwide, said Lisa Kuuttila, UNM’s chief economic development officer and head of the Science and Technology Corp., UNM’s tech transfer office.
“It’s great validation of our efforts to support startups working to commercialize UNM technology,” Kuuttila said. “It shows that our technologies and the companies licensing them are capable of attracting the attention of some of the world’s largest corporations.”